You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Boston-based firm is developing a bacterial diagnostic platform to detect antibiotic resistance and help guide antibiotic treatment in hospitals.
A GWAS that incorporated magnetic resonance imaging data for UK Biobank participants led to 45 previously undetected risk loci related to dilated cardiomyopathy.
Research institutions in the US and Europe will lead the studies, which will explore different aspects of COVID-19 such as host immune response.
In Cell this week: 'canonical digital embryo' based on single-cell RNA sequencing, genes that influence response to oxygen levels, and more.
Discover writes that polygenic risk scores could help identify people at risk of disease who might not be spotted using traditional risk factors.
The biobank will collect samples and data from Biogen employees who contracted and have recovered from COVID-19, as well as their family members and close contacts.
The three hospital laboratories' tests are all real-time PCR assays for detecting the virus from nasopharyngeal swabs and bronchoalveolar lavage.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.
The Cas9 variant can target nearly all PAM sites in the genome, allowing the researchers to edit previously inaccessible disease-relevant genetic variants.
The clinics see patients whose overall health may benefit from learning about their genetic predisposition for certain medical conditions.
Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.
Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.
A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.
In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.